Positive Phase II for intranasal antiemetic
Shin Nippon Biomedical Laboratories (SNBL) has posted a positive first report on the Phase II trial of its intranasal antiemetic, which it claims is a more convenient treatment for cancer patients.
Archives for August 3, 2009
Packaging up at AmerisourceBergen in Q3
AmerisourceBergen’s contract packaging business believes the outlook for the sector is improving after it posted an 11 per cent rise in operating income in Q3.
URL acquires PharmaPro assets
URL Pharma has acquired a 19,000 sq ft facility equipped for development and manufacture of modified release products from PharmPro.
LSR’s operating income falls
Life Sciences Research’s (LSR) operating income fell by 60 per cent to $4m (€2.8m) in Q2 but believes that the contract research market will improve later this year or in 2010.
Appointments at Dishman, CTI and PDI – People on the move
Outsourcing-Pharma presents its latest round-up of movements in the pharmaceutical outsourcing sector, including appointments at Dishman, CTI and PDI.
Lilly to train Russian FDA
Eli Lilly is among the organisations partnering to provide training for the Rozdravnadzor, Russia’s equivalent of the FDA, which is seeking to improve its knowledge of manufacturing standards.